ACHCHealthcare · Medical Care FacilitiesThe 14 Wall Street analysts covering Acadia Healthcare Co., Inc. hold a median 12-month price target of $32 — +12.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 52 of 100 as at 2 Sept 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Acadia Healthcare Co., Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (92): Reported profit is backed by cash, and the company is not expanding recklessly.
Quality (19): Profits are thin or unreliable for the size of the business, or they are not turning into cash.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on ACHC, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +12.8% from it.
Of the 20 most recent actions, 6 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 30 July 2026 | Barclays | Maintains | Equal-Weight | $25 → $32 |
| 30 July 2026 | Guggenheim | Maintains | Buy | $38 → $39 |
| 20 July 2026 | Guggenheim | Maintains | Buy | — |
| 20 July 2026 | Guggenheim | Maintains | Buy | $31 → $38 |
| 14 July 2026 | Keybanc | Maintains | Overweight | $30 → $40 |
| 14 July 2026 | Keybanc | Maintains | Overweight | — |
| 14 July 2026 | TD Cowen | Maintains | Buy | $30 → $36 |
| 14 July 2026 | TD Cowen | Maintains | Buy | — |
| 9 July 2026 | UBS | Maintains | Buy | $31 → $39 |
| 9 July 2026 | UBS | Maintains | Buy | — |
| 3 June 2026 | Jefferies | Upgrade | Buy | — |
| 4 May 2026 | Guggenheim | Maintains | Buy | — |
| 4 May 2026 | RBC Capital | Maintains | Outperform | — |
| 1 May 2026 | Barclays | Maintains | Equal-Weight | — |
| 1 May 2026 | Cantor Fitzgerald | Maintains | Neutral | — |
| 28 Apr 2026 | TD Cowen | Maintains | Buy | — |
| 17 Apr 2026 | UBS | Maintains | Buy | — |
| 3 Mar 2026 | Barclays | Maintains | Equal-Weight | — |
| 26 Feb 2026 | Leerink Partners | Maintains | Market Perform | — |
| 26 Feb 2026 | RBC Capital | Maintains | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ACHC appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 3 Sept 2026, Acadia Healthcare Co., Inc. returned +21.6% against +21.4% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 37% of US stocks
Cheaper than 75% of US stocks
Cheaper than 64% of US stocks
Cheaper than 39% of US stocks
Higher than 27% of US stocks
Higher than 7% of US stocks
Higher than 99% of US stocks
Higher than 64% of US stocks
Higher than 13% of US stocks
Higher than 24% of US stocks
Higher than 69% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Acadia Healthcare Co., Inc. has a market value of $2.6B and an enterprise value of $5.2B.
Revenue in the twelve months to 30 June 2026: $3.4B. The latest quarter shrank 0.4% year on year.
Net income over the same four quarters: −$1.1B, a −33.3% net margin.
Diluted earnings per share, trailing twelve months: $−12.45.
Free cash flow in the twelve months to 30 June 2026: −$134.0M, after $344.5M of capital spending.
Acadia Healthcare Co., Inc. spent $0.0 on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 20.6×; forward P/E: 15.5× — the forward figure prices analyst consensus estimates, not reported earnings.
Acadia Healthcare Co., Inc. employs 25,000 people — $135K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Acadia Healthcare Co., Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Acadia Healthcare reported earnings 30 days ago, and its stock has risen 11.8% since that report. The article examines what may come next for the company's shares.
Why it matters — The stock's post-earnings gain offers ACHC watchers a signal on how the market has reacted to the company's latest results.
A law firm has published a notice encouraging Acadia Healthcare shareholders to contact them regarding potential breaches of fiduciary duties by company insiders. The firm indicates it would handle any matter on a contingent fee basis with no out-of-pocket legal costs for shareholders.
Why it matters — ACHC watchers would care because this signals an investigation or potential legal action concerning insider conduct that could affect the company and its shareholders.
Acadia Healthcare, a leading pure-play behavioral healthcare provider with 279 facilities, continues to see rising revenue and a growing patient base. However, profitability is pressured by rising labor costs and a tight labor market, with higher net leverage and volatile cash flows, though shares appear attractively priced on an absolute basis.
Why it matters — ACHC watchers would care because the piece highlights the tension between the company's growing revenue and patient base versus profitability pressures from labor costs and leverage.
Kahn Swick & Foti, LLC announced it is continuing its investigation into the officers and directors of Acadia Healthcare Company, Inc. (ACHC). The investigation is being led by former Louisiana Attorney General Charles C. Foti, Jr.
Why it matters — An ongoing investigation into the company's officers and directors could draw attention among Acadia Healthcare watchers monitoring potential governance concerns.
A Seeking Alpha article discusses Acadia Healthcare's capacity expansion pipeline and strong macro demand for mental health services. It highlights the company's scale of 279 facilities and 12.6k beds as the largest independent U.S. behavioral healthcare provider, issuing a BUY rating and noting its forward EV/EBITDA of 8.8x sits below the sector median and its five-year average.
Why it matters — ACHC watchers would care because the article points to capacity expansion and favorable demand as growth drivers, with a valuation it considers discounted relative to peers and its own history.
The 14 Wall Street analysts covering Acadia Healthcare Co., Inc. have a median 12-month price target of $32, with estimates ranging from $15 to $41. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 14 analysts covering Acadia Healthcare Co., Inc., 8 rate it a Buy, 5 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Acadia Healthcare Co., Inc. 52 out of 100 across roughly 4,600 US stocks as at 2 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 2 Sept 2026, Acadia Healthcare Co., Inc. ranks 52 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (92 of 100).
No one can know that. What the data says: the median 12-month target from 14 analysts implies +12.8% from the last close, and Ticker Nerd's factor model ranks Acadia Healthcare Co., Inc. 52 out of 100 as at 2 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Acadia Healthcare Co., Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ACHC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $15 to $41 over the next 12 months.
Acadia Healthcare Co., Inc. returned +21.6% over the 12 months to 3 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
Acadia Healthcare Company, Inc. is a behavioral healthcare services provider focused on delivering treatment across a range of clinical settings.
The most recent item we track (Zacks Investment Research, 27 Aug 2026): "Acadia Healthcare (ACHC) Up 11.8% Since Last Earnings Report: Can It Continue?". Acadia Healthcare reported earnings 30 days ago, and its stock has risen 11.8% since that report. The article examines what may come next for the company's shares.
Acadia Healthcare Company, Inc. is a behavioral healthcare services provider focused on delivering treatment across a range of clinical settings. The company operates acute inpatient psychiatric facilities, specialty treatment centers, residential treatment programs, comprehensive treatment centers, and outpatient behavioral health services. Its offerings address mental health conditions, substance use disorders, and related recovery needs for patients and communities. Acadia Healthcare serves individuals through a network designed to provide both short-term stabilization and longer-term therapeutic care, making it an important participant in the U.S. behavioral health market. The company’s business is centered on facility-based care, coordinated treatment pathways, and access to specialized services across multiple levels of acuity. Founded in 2005 and headquartered in Franklin, Tennessee, Acadia Healthcare Company, Inc. remains a significant operator in the healthcare services sector.
CEO Ms. Debra K. Osteen · 25,000 employees · United States · https://www.acadiahealthcare.com
